Treatment of choroidal neovascularization associated with Best's disease in children

J Pediatr Ophthalmol Strabismus. 2009 Sep-Oct;46(5):306-11. doi: 10.3928/01913913-20090903-10. Epub 2009 Sep 22.

Abstract

The development of secondary choroidal neovascularization in Best's disease is rare in the pediatric population. A retrospective review of pediatric patients with choroidal neovascularization secondary to Best's disease was performed. The patients' courses and treatments were recorded. Three patients with choroidal neovascularization were identified. All had decreased vision and were treated in an individual manner. Vision improved after treatment in all patients. Treatment may hasten resolution of choroidal neovascularization and improve vision.

Publication types

  • Case Reports

MeSH terms

  • Angiogenesis Inhibitors / administration & dosage
  • Antibodies, Monoclonal / administration & dosage*
  • Antibodies, Monoclonal, Humanized
  • Bevacizumab
  • Child
  • Child, Preschool
  • Choroidal Neovascularization / diagnosis
  • Choroidal Neovascularization / drug therapy*
  • Choroidal Neovascularization / etiology
  • Diagnosis, Differential
  • Female
  • Fluorescein Angiography
  • Follow-Up Studies
  • Fundus Oculi
  • Glucocorticoids / administration & dosage
  • Humans
  • Injections
  • Macular Degeneration / complications*
  • Macular Degeneration / diagnosis
  • Male
  • Photochemotherapy / methods*
  • Tomography, Optical Coherence
  • Triamcinolone Acetonide / administration & dosage*
  • Vascular Endothelial Growth Factor A
  • Vitreous Body

Substances

  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Glucocorticoids
  • Vascular Endothelial Growth Factor A
  • Bevacizumab
  • Triamcinolone Acetonide